For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Bioinfra Inc.

USPTO Granted Patents = 3

% Expired Patents = 100.0

EPO Patents = 2

Forward Citations = 8

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Chul Woo Kim (3 out of 45 patents)

Yong-Sung Shin (2 out of 2 patents)

Byoung-Kwon Kim (1 out of 1 patent)

4. Syng-Yup Ohn (1 out of 1 patent)

5. Ji Young Jang (1 out of 7 patents)

6. Kil Hyon Lee (1 out of 1 patent)

7. Pil Je Park (1 out of 1 patent)

8. Mi Young Han (1 out of 1 patent)

9. Ho Sang Shin (1 out of 2 patents)

3 patents: Sort by Forward Citations

1. 8435748 - Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-R prothrombin activation peptide fragment F2 (des-R F2) in a serum (2013-05-07),

2. 8399426 - Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA (2013-03-19),

3. 7892761 - Protein markers for diagnosing stomach cancer and the diagnostic kit using them (2011-02-22),

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

3 Patents

#964 in Seoul

#2,782 in South Korea

Seoul, South Korea

Bioinfra Inc.

Forward Citations = 8

9 inventors:

Chul Woo Kim (3 out of 45 patents)

Yong-Sung Shin (2 out of 2 patents)

Byoung-Kwon Kim (1 out of 1 patent)

4. Syng-Yup Ohn (1 out of 1 patent)

5. Ji Young Jang (1 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…